Showing results (281-290 of 296) with videos related to
Sort By:
Pageof 30
Neurobiology of Disease|November 2, 2018
Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease modelsAndreas Weihofen, YuTing Liu, Joseph W Arndt, et al.Nature Communications|November 26, 2022
High-throughput screening of caterpillars as a platform to study host-microbe interactions and enteric immunityAnton G Windfelder, Frank H H Müller, Benedict Mc Larney, et al.Nature Medicine|August 7, 2007
A spatially and temporally restricted mouse model of soft tissue sarcomaDavid G Kirsch, Daniela M Dinulescu, John B Miller, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 15, 2026
Effect of clinically relevant iron oxide nanoparticles on macrophage polarization, tumor growth and tumor microenvironment modulationKarolin Roemhild, Yanchen Li, Roman A Barmin, et al.The American Journal of Pathology|April 15, 2017
Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in VitroChloe K Nobuhara, Sarah L DeVos, Caitlin Commins, et al.Neuron|December 14, 2019
Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse ModelLien Nguyen, Fabio Montrasio, Amrutha Pattamatta, et al.Cancer Discovery|January 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Saber Tadros, Matt Teater, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 26, 2023
Membrane-derived particles shed by PSMA-positive cells function as pro-angiogenic stimuli in tumorsCamila M L Machado, Magdalena Skubal, Katja Haedicke, et al.Proceedings of the National Academy of Sciences of the United States of America|January 22, 2022
Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cellsMartin K Bakht, John J Hayward, Farsheed Shahbazi-Raz, et al.Nature|September 2, 2016
The antibody aducanumab reduces Aβ plaques in Alzheimer's diseaseJeff Sevigny, Ping Chiao, Thierry Bussière, et al.Pageof 30